TABLE 2.
Predictor | Univariate analysis
|
Multivariate analysis
|
||||
---|---|---|---|---|---|---|
HR | 95% CI | p value | HR | 95% CI | p value | |
Clinical predictors | ||||||
Age, per year | 1.03 | 1.01–1.06 | 0.011 | 1.04 | 1.01–1.07 | 0.009 |
Male sex | 0.89 | 0.54–1.47 | 0.64 | – | – | – |
Preoperative predictors | ||||||
Radiographic | ||||||
Mesenteric vessel involvement | 2.25 | 0.51–9.84 | 0.28 | – | – | – |
Metastatic disease | 6.61 | 1.55–28.12 | 0.011 | 2.04 | 1.11–3.74 | 0.022 |
Tumor location | ||||||
Head | – | – | – | – | – | – |
Tail | 1.48 | 0.66–3.30 | 0.34 | – | – | – |
Tumor diameter, per cma | 1.00 | 0.86–1.17 | 0.96 | – | – | – |
Laboratory | ||||||
CA19-9, per log unitb | 1.09 | 0.97–1.21 | 0.14 | 1.09 | 0.98–1.22 | 0.12 |
CTC count, per log unit | 1.69 | 1.28–2.25 | < 0.001 | 1.38 | 1.01–1.88 | 0.040 |
HR hazard ratio, CI confidence interval, CA19-9 cancer antigen 19-9, CTC circulating tumor cell
n = 91
n = 90